Patent Assignment
Reel/Frame 037437/0849
Assignment of Assignor's Interest
Recorded: 2016-01-08
Pages: 6
Assignee
MELINTA THERAPEUTICS, INC.
300 GEORGE STREET, SUITE 301, NEW HAVEN, CONNECTICUT, 06511
Covered Properties
(2)
Crystalline Forms of D-Glucitol, 1-Deoxy-1-(Methylamino)-, 1-(6-Amino-3,5-Difluoropyridine-2-Yl)-8-Chloro-6-Fluoro-1,4-Dihydro-7-(3-Hydroxyazetidin-1-Yl)-4-Oxo-3-Quinolinecarboxylate
Application:
14/773,655 →
Publication:
US 2016/0046603
Crystalline Forms of D-Glucitol, 1-Deoxy-1-(Methylamino)-, 1-(6-Amino-3,5-Difluoropyridin-2-Yl)-8-Chloro-6-Fluoro-1,4-Dihydro-7-(3-Hydroxyazetidin-1-Yl)-4-Oxo-3-Quinolinecarboxylate
Application:
61/775,089 →
Related Assignments
(2)
Other recorded transfers of the patents in this record — the chain of ownership.
Amended and Restated Intellectual Property Security Agreement
Aug 25, 2022
From: MELINTA THERAPEUTICS, LLC
To: SILICON VALLEY BANK
Reel/Frame 061314/0459 →
Termination and Release of Intellectual Property Security Agreement (Patents) at Reel 054836 and Frame 0765 and Reel 061314 and 0459
Aug 29, 2025
From: SILICON VALLEY BANK, A DIVISION OF FIRST-CITIZENS BANK & TRUST COMPANY
To: MELINTA THERAPEUTICS, LLC
Reel/Frame 072772/0097 →